Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Commercial Officer

Chief Financial Officer

President and CEO

Chief Operating Officer

Chief Medical Officer

Chief Accounting Officer

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also developing GC4711, a dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics fo...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-19	Premium	bought	Premium	Premium	Premium	-
2024-04-18	Premium	bought	Premium	Premium	Premium	-
2024-04-17	Premium	bought	Premium	Premium	Premium	-
2024-03-28	Premium	sold	Premium	Premium	Premium	-
2024-03-27	Premium	sold	Premium	Premium	Premium	-
2024-03-26	Premium	sold	Premium	Premium	Premium	-
2024-03-25	Premium	sold	Premium	Premium	Premium	-
2024-03-22	Premium	sold	Premium	Premium	Premium	-
2024-02-08	Premium	bought	Premium	Premium	Premium	-
2024-02-07	Premium	bought	Premium	Premium	Premium	-
2024-02-06	Premium	bought	Premium	Premium	Premium	-
2024-02-05	Premium	bought	Premium	Premium	Premium	-
2024-01-30	Premium	bought	Premium	Premium	Premium	-
2024-01-29	Premium	bought	Premium	Premium	Premium	-
2024-01-11	Premium	sold	Premium	Premium	Premium	-
2023-03-16	Premium	bought	Premium	Premium	Premium	Chief Commercial Officer
2023-03-13	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-03-10	Premium	bought	Premium	Premium	Premium	President and CEO
2022-11-21	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-09-12	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-07-18	Premium	gifted	Premium	Premium	Premium	-
2021-12-17	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2021-12-17	Premium	bought	Premium	Premium	Premium	-
2021-09-01	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2021-09-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

GRTX - Galera Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for GRTX